104.59
0.56%
+0.58
アフターアワーズ:
104.47
-0.12
-0.11%
Abbott Laboratories (ABT) 最新ニュース
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
The Motley Fool
The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
Zacks Investment Research
Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
Zacks Investment Research
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Zacks Investment Research
PBH vs. ABT: Which Stock Is the Better Value Option?
Zacks Investment Research
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
The Motley Fool
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
Zacks Investment Research
Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably
Seeking Alpha
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Zacks Investment Research
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario
Seeking Alpha
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
Benzinga
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
The Motley Fool
Q1 Earnings Review
Zacks Investment Research
Markets Try to Shake Off April Blues
Zacks Investment Research
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Zacks Investment Research
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings
Benzinga
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Abbott (ABT) Tops Q1 Earnings and Revenue Estimates
Zacks Investment Research
Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point
Benzinga
Investor Optimism Decreases; Dow Ends 6-Session Losing Streak
Benzinga
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
Benzinga
Markets Mixed as Q1 Earnings, Powell Control News Headlines
Zacks Investment Research
Wall Street Breakfast: The Week Ahead
Seeking Alpha
3 Buy Rated Stocks to Consider as Earnings Approach
Zacks Investment Research
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
Zacks Investment Research
Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Research
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
Benzinga
Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable
Zacks Investment Research
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
The Motley Fool
Abbott (ABT) Rises Higher Than Market: Key Facts
Zacks Investment Research
HAE vs. ABT: Which Stock Is the Better Value Option?
Zacks Investment Research
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
Benzinga
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
The Motley Fool
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
Zacks Investment Research
The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services
Zacks Investment Research
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research
3 Top Dividend Stocks to Buy in April 2024
The Motley Fool
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks
Zacks Investment Research
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
Zacks Investment Research
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
Zacks Investment Research
Analyst Ratings For Abbott Laboratories
Benzinga
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Zacks Investment Research
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
Zacks Investment Research
Abbott (ABT) Declines More Than Market: Some Information for Investors
Zacks Investment Research
3 'Great Repeatable Business Models' (Dividend Aristocrats)
Seeking Alpha
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks Investment Research
Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark
Zacks Investment Research
大文字化:
|
ボリューム (24 時間):